Compare NVCR & TRMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVCR | TRMK |
|---|---|---|
| Founded | 2000 | 1889 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 2.3B |
| IPO Year | 2015 | 1987 |
| Metric | NVCR | TRMK |
|---|---|---|
| Price | $13.14 | $39.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $28.42 | ★ $42.67 |
| AVG Volume (30 Days) | ★ 1.5M | 299.6K |
| Earning Date | 10-30-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.46% |
| EPS Growth | N/A | ★ 10.82 |
| EPS | N/A | ★ 3.66 |
| Revenue | $642,269,000.00 | ★ $773,338,000.00 |
| Revenue This Year | $9.75 | $58.33 |
| Revenue Next Year | $5.62 | $4.57 |
| P/E Ratio | ★ N/A | $10.68 |
| Revenue Growth | 11.17 | ★ 55.58 |
| 52 Week Low | $10.70 | $29.77 |
| 52 Week High | $31.17 | $41.43 |
| Indicator | NVCR | TRMK |
|---|---|---|
| Relative Strength Index (RSI) | 54.16 | 42.31 |
| Support Level | $12.88 | $40.39 |
| Resistance Level | $13.64 | $41.33 |
| Average True Range (ATR) | 0.47 | 0.62 |
| MACD | 0.00 | -0.25 |
| Stochastic Oscillator | 49.70 | 19.57 |
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.